EXOZYMES INC.
Company Information
Industry Biological Products, (No Diagnostic Substances)
SIC Code 2836
Entity Type operating
SEC Category Non-accelerated filerSmaller reporting companyEmerging growth company
State of Incorporation NV
Business Address 750 ROYAL OAKS DR, MONROVIA, CA, 91016
Mailing Address 750 ROYAL OAKS DR, MONROVIA, CA, 91016
Phone (626) - 415 - 1488
Fiscal Year End 1231
EIN 834550057
Financial Overview
FY2025
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 10-K Annual financial report | March 30, 2026 | View on SEC |
| 8-K Current report of material events | February 5, 2026 | View on SEC |
| 424B2 Prospectus for shelf offering | January 26, 2026 | View on SEC |
| S-3 Shelf registration for future offerings | January 16, 2026 | View on SEC |
| 8-K Current report of material events | December 12, 2025 | View on SEC |
| 8-K Current report of material events | November 13, 2025 | View on SEC |
| 10-Q Quarterly financial report | November 13, 2025 | View on SEC |
| 8-K Current report of material events | October 3, 2025 | View on SEC |
| 10-Q Quarterly financial report | August 12, 2025 | View on SEC |
| 8-K Current report of material events | July 28, 2025 | View on SEC |
Annual Reports
10-K March 30, 2026
- Innovative 'cell-free' biotech platform using AI-engineered enzymes to bypass traditional cell-culture limitations.
- Eliminates toxic waste and cell death risks associated with conventional biotech manufacturing.
Related Companies
Companies in the same industry (SIC: 2836)
SANGAMO THERAPEUTICS, INC
SGMO Biological Products, (No Diagnostic Substances)
Zivo Bioscience, Inc.
ZIVO Biological Products, (No Diagnostic Substances)
Quince Therapeutics, Inc.
QNCX Biological Products, (No Diagnostic Substances)
Aura Biosciences, Inc.
AURA Biological Products, (No Diagnostic Substances)
Jasper Therapeutics, Inc.
JSPR Biological Products, (No Diagnostic Substances)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.